Stocks and Investing Stocks and Investing
Fri, January 20, 2017

Chris Schott Downgraded (TEVA) to Hold on, Jan 20th, 2017


Published on 2024-10-25 20:03:09 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Jan 20th, 2017.

Chris has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 5 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $42 on, Wednesday, November 16th, 2016
  • Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, November 16th, 2016
  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


This is the rating of the analyst that currently disagrees with Chris


  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
Contributing Sources